The Liquid Biopsy Unit (LBU) is a collaborative, translational research unit aimed at accelerating the discovery, validation and implementation of circulating free nucleic acid (cfDNA/RNA) cancer biomarkers into clinical workflows.

Get in touch

Interested in collaborating?

We can help you explore accelerate your existing projects, or help start up your first liquid biopsy project. Please fill out the onboarding form so that we can contact you to schedule our first meeting to discuss project details.